Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
securities law
Pharma
SEC tags BeiGene, Hutchmed, Zai Lab for potential delisting
The three Chinese biotechs have three years to comply with a newly installed foreign audit law or face delisting from the U.S. stock exchanges.
Angus Liu
Mar 11, 2022 10:32am
SEC pokes around FibroGen's roxadustat safety data
Mar 1, 2022 11:46am
Biocon-Viatris, AstraZeneca, Huhai and more—Fierce Pharma Asia
Nov 19, 2021 8:20am
Regulator's initial probe clears Sun Pharma of fraud: report
Aug 29, 2019 12:10pm
Korea Exchange offices raided in Samsung BioLogics IPO probe
Mar 15, 2019 11:30am
Indian regulators confirm whistleblower complaint against Sun
Dec 13, 2018 12:13pm
